272 related articles for article (PubMed ID: 31688991)
41. Serum miR-486-5p as a diagnostic marker in cervical cancer: with investigation of potential mechanisms.
Li C; Zheng X; Li W; Bai F; Lyu J; Meng QH
BMC Cancer; 2018 Jan; 18(1):61. PubMed ID: 29316891
[TBL] [Abstract][Full Text] [Related]
42. Tumor Suppressor miRNA-204-5p Regulates Growth, Metastasis, and Immune Microenvironment Remodeling in Breast Cancer.
Hong BS; Ryu HS; Kim N; Kim J; Lee E; Moon H; Kim KH; Jin MS; Kwon NH; Kim S; Kim D; Chung DH; Jeong K; Kim K; Kim KY; Lee HB; Han W; Yun J; Kim JI; Noh DY; Moon HG
Cancer Res; 2019 Apr; 79(7):1520-1534. PubMed ID: 30737233
[TBL] [Abstract][Full Text] [Related]
43. MicroRNA-1297 contributes to tumor growth of human breast cancer by targeting PTEN/PI3K/AKT signaling.
Liu C; Liu Z; Li X; Tang X; He J; Lu S
Oncol Rep; 2017 Oct; 38(4):2435-2443. PubMed ID: 28791363
[TBL] [Abstract][Full Text] [Related]
44. miR-29b regulates Ang II-induced EMT of rat renal tubular epithelial cells via targeting PI3K/AKT signaling pathway.
Hu H; Hu S; Xu S; Gao Y; Zeng F; Shui H
Int J Mol Med; 2018 Jul; 42(1):453-460. PubMed ID: 29568897
[TBL] [Abstract][Full Text] [Related]
45. circSLC8A1 sponges miR-671 to regulate breast cancer tumorigenesis via PTEN/PI3k/Akt pathway.
Zhu Q; Zhang X; Zai HY; Jiang W; Zhang KJ; He YQ; Hu Y
Genomics; 2021 Jan; 113(1 Pt 1):398-410. PubMed ID: 33301895
[TBL] [Abstract][Full Text] [Related]
46. Resveratrol upregulates miR-455-5p to antagonize cisplatin ototoxicity via modulating the PTEN-PI3K-AKT axis.
Liu Y; Wu H; Zhang F; Yang J; He J
Biochem Cell Biol; 2021 Jun; 99(3):385-395. PubMed ID: 34077275
[TBL] [Abstract][Full Text] [Related]
47. MiR-508-3p promotes proliferation and inhibits apoptosis of middle ear cholesteatoma cells by targeting PTEN/PI3K/AKT pathway.
Liu D; Ma X
Int J Med Sci; 2021; 18(14):3224-3235. PubMed ID: 34400892
[TBL] [Abstract][Full Text] [Related]
48. LncRNA FER1L4 induces apoptosis and suppresses EMT and the activation of PI3K/AKT pathway in osteosarcoma cells via inhibiting miR-18a-5p to promote SOCS5.
Ye F; Tian L; Zhou Q; Feng D
Gene; 2019 Dec; 721():144093. PubMed ID: 31473323
[TBL] [Abstract][Full Text] [Related]
49. miR-194 regulated AGK and inhibited cell proliferation of oral squamous cell carcinoma by reducing PI3K-Akt-FoxO3a signaling.
Chi H
Biomed Pharmacother; 2015 Apr; 71():53-7. PubMed ID: 25960215
[TBL] [Abstract][Full Text] [Related]
50. Circular RNA Circ_0000442 acts as a sponge of MiR-148b-3p to suppress breast cancer via PTEN/PI3K/Akt signaling pathway.
Zhang XY; Mao L
Gene; 2021 Jan; 766():145113. PubMed ID: 32891771
[TBL] [Abstract][Full Text] [Related]
51. MicroRNA-181a/b-1 over-expression enhances osteogenesis by modulating PTEN/PI3K/AKT signaling and mitochondrial metabolism.
Zheng H; Liu J; Tycksen E; Nunley R; McAlinden A
Bone; 2019 Jun; 123():92-102. PubMed ID: 30898695
[TBL] [Abstract][Full Text] [Related]
52. Triptolide Attenuates Renal Tubular Epithelial-mesenchymal Transition Via the MiR-188-5p-mediated PI3K/AKT Pathway in Diabetic Kidney Disease.
Xue M; Cheng Y; Han F; Chang Y; Yang Y; Li X; Chen L; Lu Y; Sun B; Chen L
Int J Biol Sci; 2018; 14(11):1545-1557. PubMed ID: 30263007
[TBL] [Abstract][Full Text] [Related]
53. miR-623 suppresses cell proliferation, migration and invasion through direct inhibition of XRCC5 in breast cancer.
Li Q; Liu J; Jia Y; Li T; Zhang M
Aging (Albany NY); 2020 Jun; 12(11):10246-10258. PubMed ID: 32501811
[TBL] [Abstract][Full Text] [Related]
54. miR-489 inhibits proliferation, cell cycle progression and induces apoptosis of glioma cells via targeting SPIN1-mediated PI3K/AKT pathway.
Li Y; Ma X; Wang Y; Li G
Biomed Pharmacother; 2017 Sep; 93():435-443. PubMed ID: 28666210
[TBL] [Abstract][Full Text] [Related]
55. IGF-I induces upregulation of DDR1 collagen receptor in breast cancer cells by suppressing MIR-199a-5p through the PI3K/AKT pathway.
Matà R; Palladino C; Nicolosi ML; Lo Presti AR; Malaguarnera R; Ragusa M; Sciortino D; Morrione A; Maggiolini M; Vella V; Belfiore A
Oncotarget; 2016 Feb; 7(7):7683-700. PubMed ID: 26655502
[TBL] [Abstract][Full Text] [Related]
56. miR-181d-5p promotes neurite outgrowth in PC12 Cells via PI3K/Akt pathway.
Shen LM; Song ZW; Hua Y; Chao X; Liu JB
CNS Neurosci Ther; 2017 Nov; 23(11):894-906. PubMed ID: 28961370
[TBL] [Abstract][Full Text] [Related]
57. miR-142-5p promotes the osteoclast differentiation of bone marrow-derived macrophages via PTEN/PI3K/AKT/FoxO1 pathway.
Lou Z; Peng Z; Wang B; Li X; Li X; Zhang X
J Bone Miner Metab; 2019 Sep; 37(5):815-824. PubMed ID: 30900017
[TBL] [Abstract][Full Text] [Related]
58. miR-222 induces Adriamycin resistance in breast cancer through PTEN/Akt/p27
Wang DD; Yang SJ; Chen X; Shen HY; Luo LJ; Zhang XH; Zhong SL; Zhao JH; Tang JH
Tumour Biol; 2016 Nov; 37(11):15315-15324. PubMed ID: 27699665
[TBL] [Abstract][Full Text] [Related]
59. Exosomes of bone-marrow stromal cells inhibit cardiomyocyte apoptosis under ischemic and hypoxic conditions via miR-486-5p targeting the PTEN/PI3K/AKT signaling pathway.
Sun XH; Wang X; Zhang Y; Hui J
Thromb Res; 2019 May; 177():23-32. PubMed ID: 30844685
[TBL] [Abstract][Full Text] [Related]
60. MicroRNA-21 promotes cell proliferation, migration, and resistance to apoptosis through PTEN/PI3K/AKT signaling pathway in esophageal cancer.
Wu YR; Qi HJ; Deng DF; Luo YY; Yang SL
Tumour Biol; 2016 Sep; 37(9):12061-12070. PubMed ID: 27188433
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
